01.03.2000 | ORIGINAL ARTICLE
Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 1/2000
Einloggen, um Zugang zu erhalten